TS
BEAM icon

Thomas Steyer’s Beam Therapeutics BEAM Stock Holding History

Thomas Steyer’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351M Buy
10,236,396
+101,700
+1% +$3.07M 1.62% 21
2026
Q1 		$242M Buy
10,134,696
+71,585
+0.7% +$1.99M 1.27% 27
2025
Q4 		$279M Hold
10,063,111
– – 1.21% 30
2025
Q3 		$244M Buy
10,063,111
+50,000
+0.5% +$995K 1% 33
2025
Q2 		$170M Buy
10,013,111
+85,000
+0.9% +$1.48M 0.72% 40
2025
Q1 		$194M Buy
9,928,111
+1,688,988
+20% +$44.2M 0.93% 38
2024
Q4 		$204M Buy
8,239,123
+31,000
+0.4% +$791K 0.9% 39
2024
Q3 		$201M Buy
8,208,123
+295,000
+4% +$7.62M 0.88% 39
2024
Q2 		$185M Buy
7,913,123
+3,401,370
+75% +$83.5M 0.8% 39
2024
Q1 		$149M Buy
4,511,753
+406,000
+10% +$12.6M 0.63% 39
2023
Q4 		$112M Sell
4,105,753
-376,086
-8% -$9.34M 0.51% 44
2023
Q3 		$108M Buy
4,481,839
+1,040,317
+30% +$27.9M 0.5% 39
2023
Q2 		$110M Buy
3,441,522
+9,601
+0.3% +$312K 0.55% 47
2023
Q1 		$105M Buy
3,431,921
+32,000
+0.9% +$1.26M 0.57% 48
2022
Q4 		$133M Sell
3,399,921
-231,350
-6% -$10.4M 0.79% 41
2022
Q3 		$173M Buy
3,631,271
+159,000
+5% +$9.07M 0.95% 39
2022
Q2 		$134M Buy
3,472,271
+877,884
+34% +$34.9M 0.73% 44
2022
Q1 		$149M Buy
2,594,387
+329,342
+15% +$21.6M 0.72% 38
2021
Q4 		$181M Buy
2,265,045
+547,455
+32% +$46.9M 0.9% 34
2021
Q3 		$149M Buy
1,717,590
+217,590
+15% +$21.9M 0.7% 42
2021
Q2 		$193M Buy
1,500,000
+907,519
+153% +$72.3M 0.79% 38
2021
Q1 		$47.4M Buy
+592,481
New +$56.4M 0.24% 74
2020
Q2 		– Sell
-170,164
Closed -$3.06M – 121
2020
Q1 		$3.06M Buy
+170,164
New +$3.7M 0.03% 91

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Thomas Steyer's BEAM Position: Q2 2026 in Review

Thomas Steyer increased its Beam Therapeutics (BEAM) stake by 1% in Q2 2026, buying an estimated $3.07M and bringing the position to 10,236,396 shares worth $351M. The position accounts for 1.62% of the portfolio, ranked #21.

Thomas Steyer first reported a position in BEAM in Q1 2020 and has held it in 23 quarters since. 275 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • Thomas Steyer held 10,236,396 shares of Beam Therapeutics worth $351M as of Q2 2026.
  • Thomas Steyer bought 101,700 Beam Therapeutics shares in Q2 2026, an estimated $3.07M.
  • Beam Therapeutics made up 1.62% of Thomas Steyer's portfolio in Q2 2026, its #21 holding.
  • Thomas Steyer first reported a position in Beam Therapeutics in Q1 2020 and has held it in 23 quarters since.
  • 275 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.